SEI INVESTMENTS CO - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
SEI INVESTMENTS CO ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$5,592,348
+9.0%
361,480
+10.6%
0.01%
+11.1%
Q2 2023$5,132,855
-0.4%
326,693
+4.5%
0.01%
-10.0%
Q1 2023$5,152,058
+0.4%
312,624
-5.0%
0.01%
-9.1%
Q4 2022$5,131,206
+26.0%
328,912
+4.7%
0.01%
+22.2%
Q3 2022$4,073,000
-2.7%
314,040
+4.0%
0.01%0.0%
Q2 2022$4,185,000
+12.2%
301,913
+15.1%
0.01%
+28.6%
Q1 2022$3,730,000
-9.0%
262,380
-13.1%
0.01%
-12.5%
Q4 2021$4,099,000
-23.2%
301,909
-7.6%
0.01%
-27.3%
Q3 2021$5,337,000
-4.3%
326,620
-1.4%
0.01%
-8.3%
Q2 2021$5,574,000
+15.5%
331,195
+24.8%
0.01%0.0%
Q1 2021$4,827,0000.0%265,3710.0%0.01%0.0%
Q4 2020$4,827,000
+26.2%
265,371
+24.7%
0.01%
+9.1%
Q3 2020$3,825,000
-25.9%
212,759
-25.9%
0.01%
-31.2%
Q2 2020$5,165,000
-4.3%
287,019
-18.8%
0.02%
-20.0%
Q1 2020$5,397,000
-20.8%
353,670
+2.2%
0.02%0.0%
Q4 2019$6,813,000
+7.8%
346,003
-5.5%
0.02%
+25.0%
Q3 2019$6,321,000
-5.9%
366,121
-3.5%
0.02%
-27.3%
Q2 2019$6,715,000
+1.9%
379,210
+16.9%
0.02%0.0%
Q1 2019$6,593,000
+35.2%
324,405
+12.6%
0.02%
+29.4%
Q4 2018$4,878,000288,2310.02%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders